Many large research initiatives have cumulatively enrolled thousands of patients with a range of complex medical issues but no clear genetic etiology. However, it is unclear how researchers, institutions and funders should manage the data and relationships with those participants who remain undiagnosed when these studies end. In this Comment, we outline the current literature relevant to post-study obligations in clinical genomics research and discuss the application of current guidelines to research with undiagnosed participants.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Ramoni, R. B. et al. Am. J. Hum. Genet. 100, 185–192 (2017).
Amendola, L. M. et al. Am. J. Hum. Genet. 103, 319–327 (2018).
Baxter, S. M. et al. Genet. Med. 24, 784–797 (2022).
Taruscio, D. et al. Mol. Genet. Metab. 129, 243–254 (2020).
100,000 Genomes Pilot Project Investigators. N. Engl. J. Med. 385, 1868–1880 (2021).
Zurek, B. et al. Eur. J. Hum. Genet. 29, 1325–1331 (2021).
Splinter, K. et al. N. Engl. J. Med. 379, 2131–2139 (2018).
National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. US Department of Health and Human Services https://www.hhs.gov/ohrp/regulations-and-policy/belmont-report/read-the-belmont-report/index.html (1979).
Richardson, H. S. & Belsky, L. Hastings Cent. Rep. 34, 25–33 (2004).
Cho, H. L., Danis, M. & Grady, C. Lancet 391, 1478–1479 (2018).
Cho, H. L., Danis, M. & Grady, C. Clin. Trials 15, 509–521 (2018).
World Medical Association. J. Am. Med. Assoc. 310, 2191–2194 (2013).
Halley, M. C. et al. Am. J. Med. Genet. A. 188, 1088–1101 (2022).
Appelbaum, P. S., Roth, L. H., Lidz, C. W., Benson, P. & Winslade, W. Hastings Cent. Rep. 17, 20–24 (1987).
Carrieri, D. et al. Eur. J. Hum. Genet. 27, 169–182 (2019).
Pyeritz, R. E. N. Engl. J. Med. 365, 1367–1369 (2011).
Bombard, Y. et al. Am. J. Hum. Genet. 104, 578–595 (2019).
Beskow, L. M. & Burke, W. Sci. Transl. Med. 2, 38cm20 (2010).
Jarvik, G. P. et al. Am. J. Hum. Genet. 94, 818–826 (2014).
Weiner, C. Am. J. Epidemiol. 180, 562–564 (2014).
Middleton, A. et al. Lancet 385, 1289–1290 (2015).
Richardson, H. S. & Cho, M. K. Genet. Med. 14, 467–472 (2012).
Tan, N. B. et al. Mol. Genet. Genomic Med. 8, e1508 (2020).
Marwaha, S., Knowles, J. W. & Ashley, E. A. Genome Med. 14, 23 (2022).
Morain, S. & Largent, E. Am. J. Bioeth. https://doi.org/10.1080/15265161.2022.2063435 (2022).
Reuter,, C. M. et al. J. Genet. Couns. 28, 1107–1118 (2019).
Boycott, K. M. et al. Cell 177, 32–37 (2019).
Kohane, I. S. et al. Science 316, 836–837 (2007).
Prictor, M. et al. J. Empir. Res. Hum. Res. Ethics 15, 175–186 (2020).
Tabor, H. K. et al. Genet. Med. 19, 467–475 (2017).
Acknowledgements
Financial support for this work was provided by the National Institutes of Health Common Fund, Office of the Director, as an administrative supplement to grant number U01HG010218-03S2 (E.A.A.). M.C.H. also is supported by the National Human Genome Research Institute grant number K01HG011341, and H.K.T. also is supported by the National Center for Advancing Translational Science grant number UL1TR003142.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
E.A.A. is co-founder to Personalis, DeepCell and Svexa; non-executive director to AstraZeneca; and advisor to Genome Medical, Sequence Bio, Apple and Foresite Capital. As a volunteer, M.C.H. is co-chair of the Undiagnosed Diseases Network Patient Education and Empowerment Resource and is a member of the Board of Directors of the Undiagnosed Diseases Network Foundation; both roles are uncompensated. H.K.T. declares no competing interests.
Rights and permissions
About this article
Cite this article
Halley, M.C., Ashley, E.A. & Tabor, H.K. Supporting undiagnosed participants when clinical genomics studies end. Nat Genet 54, 1063–1065 (2022). https://doi.org/10.1038/s41588-022-01150-8
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41588-022-01150-8